Healthcare - Biotechnology - NASDAQ - US
$ 28.39
-6.33 %
$ 2.85 B
Market Cap
-7.93
P/E
BALANCE SHEET
165 M
ASSETS
73.8 M
LIABILITIES
91.3 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Dyne Therapeutics, Inc.
| Current Assets | 129 M |
| Cash & Short-Term Investments | 123 M |
| Receivables | 0 |
| Other Current Assets | 6.28 M |
| Non-Current Assets | 35.7 M |
| Long-Term Investments | 0 |
| PP&E | 33.4 M |
| Other Non-Current Assets | 2.32 M |
| Current Liabilities | 51.1 M |
| Accounts Payable | 22.9 M |
| Short-Term Debt | 9.44 M |
| Other Current Liabilities | 18.7 M |
| Non-Current Liabilities | 22.7 M |
| Long-Term Debt | 45.4 M |
| Other Non-Current Liabilities | -22.7 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Cash & Cash Equivalents | 121.6 | 172.1 | 200.8 | 300.9 | 14.6 | 8.1 | 365.0 | 1 776.0 | 505.0 | 1 870.0 | 843.0 | 348.0 | 396.0 | 291.0 | 471.0 | 693.0 | 328.0 |
| Short Term Investments | 1.5 | 83.9 | 175.7 | 44.5 | 0 | 0 | 32.0 | 130.0 | 100.0 | 78.0 | 25.0 | 13.0 | 69.0 | 106.0 | 78.0 | 87.0 | 104.0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 513.0 | 386.0 | 402.0 | 270.0 | 420.0 | 108.0 | 6.0 | 230.0 | 212.0 | 340.0 | 426.0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 445.0 | 445.0 | 597.0 | 208.0 | 181.0 | 101.0 | 57.0 | 121.0 | 141.0 | 184.0 | 199.0 |
| Other Current Assets | 6.3 | 9.6 | 11.6 | 7.5 | 0.3 | 34 K | 169.0 | 250.0 | 341.0 | 248.0 | 216.0 | 473.0 | 144.0 | 1 496.0 | 1 136.0 | 1 499.0 | 606.0 |
| Total Current Assets | 129.4 | 256.0 | 382.4 | 345.3 | 14.8 | 8.2 | 1 524.0 | 2 987.0 | 1 945.0 | 2 674.0 | 1 685.0 | 1 043.0 | 672.0 | 2 244.0 | 2 038.0 | 2 803.0 | 1 663.0 |
| PP&E | 33.4 | 38.4 | 41.0 | 1.9 | 1.5 | 0.1 | 8 884.0 | 7 121.0 | 8 347.0 | 3 255.0 | 3 315.0 | 3 022.0 | 3 334.0 | 6 273.0 | 9 071.0 | 10 869.0 | 10 689.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 25.0 | 38.0 | 102.0 | 27.0 | 108.0 | 271.0 | 0 | 141.0 | 380.0 | 437.0 | 497.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 772.0 | 799.0 | 797.0 | 0 | 0 | 0 | 0 | 0 | 0 | 433.0 | 438.0 |
| Long Term Investments | 0 | 2.3 | 2.3 | 2.3 | 0 | 0 | 26.0 | 16.0 | 18.0 | 2.0 | 11.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 2.3 | 9.6 | 0 | 3.8 | 0.2 | 0 | (31.0) | 1 665.0 | 330.0 | 5 254.0 | 72.0 | 181.0 | 116.0 | 1 343.0 | (536.0) | (329.0) | (66.0) |
| Other Assets | 0 | 0 | 0 | 0 | 1 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 165.1 | 306.3 | 425.7 | 353.3 | 16.4 | 8.3 | 11 771.0 | 13 053.0 | 11 539.0 | 11 232.0 | 5 291.0 | 4 535.0 | 4 127.0 | 10 013.0 | 10 953.0 | 14 213.0 | 13 221.0 |
| LIABILITIES | |||||||||||||||||
| Accounts Payable | 22.9 | 5.3 | 4.0 | 3.4 | 1.3 | 0.5 | 367.0 | 332.0 | 292.0 | 216.0 | 329.0 | 112.0 | 15.0 | 134.0 | 181.0 | 303.0 | 292.0 |
| Short Term Debt | 9.4 | 9.2 | 7.8 | 0 | 0 | 0 | 105.0 | 201.0 | 83.0 | 31.0 | 13.0 | 29.0 | 4.0 | 148.0 | 807.0 | 64.0 | 51.0 |
| Other Current Liabilities | 18.7 | 13.6 | 16.9 | 7.5 | 1.1 | 0.2 | 506.0 | 375.0 | 405.0 | 410.0 | 5.0 | 110.0 | 135.0 | 1 271.0 | 853.0 | 1 329.0 | 611.0 |
| Total Current Liabilities | 51.1 | 28.1 | 28.7 | 11.0 | 2.4 | 0.7 | 1 049.0 | 916.0 | 812.0 | 681.0 | 721.0 | 347.0 | 159.0 | 1 565.0 | 1 847.0 | 1 702.0 | 999.0 |
| Long Term Debt | 45.4 | 51.7 | 57.5 | 0 | 0 | 3.4 | 8 328.0 | 8 778.0 | 7 206.0 | 7 075.0 | 1 979.0 | 1 386.0 | 584.0 | 4 426.0 | 807.0 | 64.0 | 51.0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 7.0 | 5.0 | 29.0 | 20.0 | 100.0 | 95.0 | 5.0 | 641.0 | 0 | 0 | 0 |
| Other Liabilities | (22.7) | (25.9) | (28.7) | 0 | 42 K | 9.1 | 146.0 | 170.0 | 183.0 | 217.0 | 178.0 | 257.0 | 145.0 | 336.0 | 359.0 | 500.0 | 388.0 |
| Total Liabilities | 73.8 | 54.0 | 57.5 | 11.0 | 2.4 | 13.1 | 9 870.0 | 11 011.0 | 8 618.0 | 8 209.0 | 3 081.0 | 2 032.0 | 3 015.0 | 7 267.0 | 7 974.0 | 9 728.0 | 8 692.0 |
| EQUITY | |||||||||||||||||
| Common Stock | 6 K | 6 K | 6 K | 5 K | 1 K | 1 K | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 6.0 | 5.0 | 5.0 |
| Retained Earnings | (632.5) | (396.6) | (228.5) | (79.2) | (19.7) | (4.9) | (1 851.0) | (1 927.0) | (686.0) | (736.0) | (463.0) | (107.0) | (4 841.0) | (3 196.0) | 0 | 0 | 0 |
| Other Accumulative Comprehensive Income/Loss | 0 | (0.6) | (0.3) | 27 K | 0 | 24 K | 32.0 | 21.0 | 19.0 | 20.0 | 58.0 | 11.0 | (53.0) | (53.0) | (150.0) | (215.0) | (25.0) |
| Total Equity | 91.3 | 252.4 | 368.2 | 342.4 | 14.0 | (4.9) | 1 901.0 | 2 042.0 | 2 921.0 | 3 023.0 | 2 210.0 | 2 503.0 | 1 112.0 | 2 746.0 | 2 902.0 | 4 515.0 | 4 506.0 |
| Total Liabilities and Equity | 165.1 | 306.3 | 425.7 | 353.3 | 16.4 | 8.3 | 11 771.0 | 13 053.0 | 11 539.0 | 11 232.0 | 5 291.0 | 4 535.0 | 4 127.0 | 10 013.0 | 10 953.0 | 14 213.0 | 13 221.0 |
| SHARES OUTSTANDING | |||||||||||||||||
| Common Shares Outstanding | 59.7 | 52.0 | 50.9 | 14.4 | 45.4 | 10.3 | 162.0 | 129.0 | 125.0 | 126.0 | 100.0 | 100.0 | 122.0 | 120.0 | 1 009.6 | 870.0 | 1 760.0 |